Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease [Yahoo! Finance]
Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
Aldeyra Therapeutics, Inc (NASDAQ: ALDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.